New-onset, untreated patients with MS show significant reductions in IgA-bound fecal microbiota, as well as changes in the abundance and prevalence of specific gut bacterial strains within both the total and IgA-bound bacterial fractions. Here, CD79A is linked to myeloid sarcoma.